-
Host miR-129-5p reverses effects of ginsenoside Rg1 on morphine reward possibly mediated by changes in B. vulgatus and serotonin metabolism in hippocampus Gut Microbes (IF 12.2) Pub Date : 2023-09-12 Chan Li, Yingbo Lin, Rukun Lin, Zhijie Chen, Qichun Zhou, Chaohua Luo, Zhixian Mo
ABSTRACT Morphine addiction is closely associated with dysbiosis of the gut microbiota. miRNAs play a crucial role in regulating intestinal bacterial growth and are involved in the development of disease. Ginsenoside Rg1 exhibits an anti-addiction effect and significantly improves intestinal microbiota disorders. In pseudo-germfree mice, supplementation with Bacteroides vulgatus (B. vulgatus) synergistically
-
Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling Gut Microbes (IF 12.2) Pub Date : 2023-09-12 Heather A. Danhof, Jihwan Lee, Aanchal Thapa, Robert A. Britton, Sara C. Di Rienzi
ABSTRACT Intestinal microbes impact the health of the intestine and organs distal to the gut. Limosilactobacillus reuteri is a human intestinal microbe that promotes normal gut transit, the anti-inflammatory immune system, wound healing, normal social behavior in mice, and prevents bone reabsorption. Oxytocin impacts these functions and oxytocin signaling is required for L. reuteri-mediated wound healing
-
Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease Gut Microbes (IF 12.2) Pub Date : 2023-09-15 C. Delprete, R. Rimondini Giorgini, E. Lucarini, T.F.S. Bastiaanssen, D. Scicchitano, N. Interino, F. Formaggio, F. Uhlig, C. Ghelardini, N.P. Hyland, J.F. Cryan, R. Liguori, M. Candela, J. Fiori, S. Turroni, L. Di Cesare Mannelli, M. Caprini
ABSTRACT Fabry disease (FD) is an X-linked metabolic disease caused by a deficiency in α-galactosidase A (α-Gal A) activity. This causes accumulation of glycosphingolipids, especially globotriaosylceramide (Gb3), in different cells and organs. Neuropathic pain and gastrointestinal (GI) symptoms, such as abdominal pain, nausea, diarrhea, constipation, and early satiety, are the most frequent symptoms
-
Distinctive patterns of sulfide- and butyrate-metabolizing bacteria after bariatric surgery: potential implications for colorectal cancer risk Gut Microbes (IF 12.2) Pub Date : 2023-09-13 Hisham Hussan, Steven K. Clinton, Elizabeth M. Grainger, Maxine Webb, Cankun Wang, Amy Webb, Bradley Needleman, Sabrena Noria, Jiangjiang Zhu, Fouad Choueiry, Maciej Pietrzak, Michael T. Bailey
ABSTRACT Despite improved cardiometabolic outcomes following bariatric surgery, its long-term impact on colorectal cancer (CRC) risk remains uncertain. In parallel, the influence of bariatric surgery on the host microbiome and relationships with disease outcomes is beginning to be appreciated. Therefore, we investigated the impact of Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG)
-
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy Gut Microbes (IF 12.2) Pub Date : 2023-09-07 Jacobo de la Cuesta-Zuluaga, Kelsey E. Huus, Nicholas D. Youngblut, Juan S. Escobar, Ruth E. Ley
ABSTRACT Obesity (OB) and cardiometabolic disease are major public health issues linked to changes in the gut microbiome. OB and poor cardiometabolic health status (CHS) are often comorbid, which hinders efforts to identify components of the microbiome uniquely linked to either one. Here, we used a deeply phenotyped cohort of 408 adults from Colombia, including subjects with OB, unhealthy CHS, or both
-
Targeting microbial quorum sensing: the next frontier to hinder bacterial driven gastrointestinal infections Gut Microbes (IF 12.2) Pub Date : 2023-09-07 Ying Su, Tao Ding
ABSTRACT Bacteria synchronize social behaviors via a cell-cell communication and interaction mechanism termed as quorum sensing (QS). QS has been extensively studied in monocultures and proved to be intensively involved in bacterial virulence and infection. Despite the role QS plays in pathogens during laboratory engineered infections has been proved, the potential functions of QS related to pathogenesis
-
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms Gut Microbes (IF 12.2) Pub Date : 2023-09-05 Viviani Mendes de Almeida, Daiane F. Engel, Mayra F. Ricci, Clênio Silva Cruz, Ícaro Santos Lopes, Daniele Almeida Alves, Mirna d’ Auriol, João Magalhães, Elayne C. Machado, Victor M. Rocha, Toniana G. Carvalho, Larisse S. B. Lacerda, Jordane C. Pimenta, Mariana Aganetti, Giuliana S. Zuccoli, Bradley J. Smith, Victor C. Carregari, Erika da Silva Rosa, Izabela Galvão, Geovanni Dantas Cassali, Cristiana
ABSTRACT Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host gut microbiota, which is linked to disease severity in patients with COVID-19. Here, we report that the gut microbiota of post-COVID subjects had a remarkable predominance of Enterobacteriaceae strains with an antibiotic-resistant
-
Lactobacillus johnsonii N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature Gut Microbes (IF 12.2) Pub Date : 2023-09-07 Alexandra E. Cuaycal, Leandro Dias Teixeira, Graciela L. Lorca, Claudio F. Gonzalez
ABSTRACT Shifts in the gut microbiota composition, called dysbiosis, have been directly associated with acute and chronic diseases. However, the underlying biological systems connecting gut dysbiosis to systemic inflammatory pathologies are not well understood. Phospholipids (PLs) act as precursors of both, bioactive inflammatory and resolving mediators. Their dysregulation is associated with chronic
-
Akkermansia muciniphila supplementation prevents cognitive impairment in sleep-deprived mice by modulating microglial engulfment of synapses Gut Microbes (IF 12.2) Pub Date : 2023-09-06 Na Li, Shuwen Tan, Yue Wang, Jiao Deng, Nan Wang, Shan Zhu, Wen Tian, Jing Xu, Qiang Wang
ABSTRACT The microbiome-gut-brain axis plays a crucial role in many neurological diseases, including mild cognitive impairment. Sleep deprivation (SD) induces cognitive decline accompanied by alterations in the gut microbiota. However, the role of gut microbiota alterations in SD-induced cognitive dysfunction and the underlying mechanisms remain unclear. Here, we found that dysbiosis of the gut microbiota
-
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective study Gut Microbes (IF 12.2) Pub Date : 2023-08-30 Hatim Boughanem, Patricia Ruiz-Limón, Jesús Pilo, José Manuel Lisbona-Montañez, Francisco J. Tinahones, Isabel Moreno Indias, Manuel Macías-González
ABSTRACT Vitamin D, microbiota, and the Mediterranean diet (MedDiet) have been the focus of recent research due to their potential role in maintaining overall health. We hypothesize that MedDiet may alter the gut microbiota profile through changes in vitamin D levels. We aimed to investigate changes in gut microbiota and serum vitamin D levels after a MedDiet within a lifestyle intervention. The study
-
The curious case of Prevotella copri Gut Microbes (IF 12.2) Pub Date : 2023-09-01 Nehal Adel Abdelsalam, Shaimaa M. Hegazy, Ramy K. Aziz
ABSTRACT Prevotella copri is an abundant member of the human gastrointestinal microbiome, whose relative abundance has curiously been associated with positive and negative impacts on diseases, such as Parkinson’s disease and rheumatoid arthritis. Yet, the verdict is still out on the definitive role of P. copri in human health, and on the effect of different diets on its relative abundance in the gut
-
Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis Gut Microbes (IF 12.2) Pub Date : 2023-09-01 Ghaffar Muharram, Marion Thépaut, Pierre-Emmanuel Lobert, Teddy Grandjean, Olivier Boulard, Myriam Delacre, Emmrich Wakeford, Richard Wheeler, Lionel Franz Poulin, Ivo Gomperts Boneca, Frank Lafont, Marie-Cécile Michallet, Didier Hober, Ken Cadwell, Mathias Chamaillard
ABSTRACT Over 90% of epidemic non-bacterial gastroenteritis are caused by human noroviruses (NoVs), which persist in a substantial subset of people allowing their spread worldwide. This has led to a significant number of endemic cases and up to 70,000 children deaths in developing countries. NoVs are primarily transmitted through the fecal-oral route. To date, studies have focused on the influence
-
Ring1a protects against colitis through regulating mucosal immune system and colonic microbial ecology Gut Microbes (IF 12.2) Pub Date : 2023-09-01 Yashu Wang, Qianru Li, Jiayu Zhang, Pingping Liu, Huaixin Zheng, Lijuan Chen, Zhen Wang, Chen Tan, Min Zhang, Hongxia Zhang, Wenqing Miao, Yuke Wang, Xiaoyan Xuan, Guoqiang Yi, Peng Wang
ABSTRACT Inflammatory bowel disease (IBD) represents a prominent chronic immune-mediated inflammatory disorder, yet its etiology remains poorly comprehended, encompassing intricate interactions between genetics, immunity, and the gut microbiome. This study uncovers a novel colitis-associated risk gene, namely Ring1a, which regulates the mucosal immune response and intestinal microbiota. Ring1a deficiency
-
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents Gut Microbes (IF 12.2) Pub Date : 2023-08-29 Alex E. Mohr, Mary M. Ahern, Dorothy D. Sears, Meg Bruening, Corrie M. Whisner
ABSTRACT Significant human gut microbiome changes during adolescence suggest that microbial community evolution occurs throughout important developmental periods including the transition to college, a typical life phase of weight gain. In this observational longitudinal study of 139 college freshmen living in on-campus dormitories, we tracked changes in the gut microbiome via 16S amplicon sequencing
-
Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer Gut Microbes (IF 12.2) Pub Date : 2023-08-27 Wenxing Gao, Xiang Gao, Lixin Zhu, Sheng Gao, Ruicong Sun, Zhongsheng Feng, Dingfeng Wu, Zhanju Liu, Ruixin Zhu, Na Jiao
ABSTRACT Microbial signatures show remarkable potentials in predicting colorectal cancer (CRC). This study aimed to evaluate the diagnostic powers of multimodal microbial signatures, multi-kingdom species, genes, and single-nucleotide variants (SNVs) for detecting precancerous adenomas. We performed cross-cohort analyses on whole metagenome sequencing data of 750 samples via xMarkerFinder to identify
-
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell Gut Microbes (IF 12.2) Pub Date : 2023-08-27 Xinhai Zhu, Ke Li, Guichao Liu, Ruan Wu, Yan Zhang, Siying Wang, Meng Xu, Ligong Lu, Peng Li
ABSTRACT Recent studies have demonstrated that the antitumor immunity of immune cells can be modulated by gut microbiota and their metabolites. However, the underlying mechanisms remain unclear. Here, we showed that the serum butyric acid level is positively correlated with the expression of programmed cell death-1 (PD-1) on circulating CD8+ and Vγ9 Vδ2 (Vδ2+) T cells in patients with non-small cell
-
Statistical normalization methods in microbiome data with application to microbiome cancer research Gut Microbes (IF 12.2) Pub Date : 2023-08-25 Yinglin Xia
ABSTRACT Mounting evidence has shown that gut microbiome is associated with various cancers, including gastrointestinal (GI) tract and non-GI tract cancers. But microbiome data have unique characteristics and pose major challenges when using standard statistical methods causing results to be invalid or misleading. Thus, to analyze microbiome data, it not only needs appropriate statistical methods,
-
The microbiome landscape in pediatric Crohn’s disease and therapeutic implications Gut Microbes (IF 12.2) Pub Date : 2023-08-23 Karin Fetter, Markus Weigel, Benjamin Ott, Moritz Fritzenwanker, Sebastian Stricker, Jan de Laffolie, Torsten Hain
ABSTRACT Dysbiosis of the gut microbiome and a pathological immune response in intestinal tissues form the basis of Crohn’s disease (CD), which is a debilitating disease with relevant morbidity and mortality. It is increasing in childhood and adolescents, due to western life-style and nutrition and a large set of predisposing genetic factors. Crohn’s disease-associated genetic mutations play an essential
-
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions Gut Microbes (IF 12.2) Pub Date : 2023-08-24 Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, Kin Lam Yu, Sj Shen, Amany Zekry
ABSTRACT Hepatocellular carcinoma (HCC) has been linked to the gut microbiota, with recent studies revealing the potential of gut-generated responses to influence several arms of the immune responses relevant to HCC formation. The pro- or anti-tumor effects of specific bacterial strains or gut microbiota-related metabolites, such as bile acids and short-chain fatty acids, have been highlighted in many
-
Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial Gut Microbes (IF 12.2) Pub Date : 2023-08-23 Xiaoqin Li, Shan Hu, Jiawei Yin, Xiaobo Peng, Lei King, Linyan Li, Zihui Xu, Li Zhou, Zhao Peng, Xiaolei Ze, Xuguang Zhang, Qiangchuan Hou, Zhilei Shan, Liegang Liu
ABSTRACT Synbiotics are increasingly used by the general population to boost immunity. However, there is limited evidence concerning the immunomodulatory effects of synbiotics in healthy individuals. Therefore, we conducted a double-blind, randomized, placebo-controlled study in 106 healthy adults. Participants were randomly assigned to receive either synbiotics (containing Bifidobacterium lactis HN019
-
Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study Gut Microbes (IF 12.2) Pub Date : 2023-08-24 Javier Moleón, Cristina González-Correa, Iñaki Robles-Vera, Sofía Miñano, Néstor de la Visitación, Antonio Manuel Barranco, Natividad Martín-Morales, Francisco O’Valle, Laura Mayo-Martínez, Antonia García, Marta Toral, Rosario Jiménez, Miguel Romero, Juan Duarte
ABSTRACT This study is to investigate whether dietary fiber intake prevents vascular and renal damage in a genetic mouse model of systemic lupus erythematosus (SLE), and the contribution of gut microbiota in the protective effects. Female NZBWF1 (SLE) mice were treated with resistant-starch (RS) or inulin-type fructans (ITF). In addition, inoculation of fecal microbiota from these experimental groups
-
Bifidobacterium infantis utilizes N-acetylglucosamine-containing human milk oligosaccharides as a nitrogen source Gut Microbes (IF 12.2) Pub Date : 2023-08-23 Shuqi Li, Xiaomeng You, Asha Rani, Ezgi Özcan, David A. Sela
ABSTRACT Bifidobacterium longum subsp. infantis (B. infantis) utilizes oligosaccharides secreted in human milk as a carbohydrate source. These human milk oligosaccharides (HMOs) integrate the nitrogenous residue N-acetylglucosamine (NAG), although HMO nitrogen utilization has not been described to date. Herein, we characterize the B. infantis nitrogen utilization phenotype on two NAG-containing HMO
-
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use Gut Microbes (IF 12.2) Pub Date : 2023-08-23 Udhghatri Kolli, Richa Jalodia, Shamsudheen Moidunny, Praveen Kumar Singh, Yuguang Ban, Junyi Tao, Gonzalo Nathaniel Cantu, Eridania Valdes, Sundaram Ramakrishnan, Sabita Roy
ABSTRACT Opioid crisis is an ongoing epidemic since the past several decades in the United States. Opioid use-associated microbial dysbiosis is emerging as a key regulator of intestinal homeostasis and behavioral responses to opioid. However, the mechanistic insight into the role of microbial community in modulating host response is unavailable. To uncover the role of opioid-induced dysbiosis in disrupting
-
Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort study Gut Microbes (IF 12.2) Pub Date : 2023-08-23 Alessandro Atzeni, Stephanie K. Nishi, Nancy Babio, Clara Belzer, Prokopis Konstanti, Jesús Vioque, Dolores Corella, Olga Castañer, Josep Vidal, Isabel Moreno-Indias, Laura Torres-Collado, Eva M. Asensio, Montserrat Fitó, Ana Maria Gomez-Perez, Alejandro Arias, Miguel Ruiz-Canela, Frank B. Hu, Francisco J. Tinahones, Jordi Salas-Salvadó
ABSTRACT The impact of carbohydrate quality, measured by the carbohydrate quality index (CQI), on gut microbiota and health has been scarcely investigated. The aim of this study was to cross-sectionally and longitudinally explore the relationships between CQI, fecal microbiota, and cardiometabolic risk factors in an elderly Mediterranean population at high cardiovascular risk. At baseline and 1-year
-
Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces Gut Microbes (IF 12.2) Pub Date : 2023-08-18 Lucía Huertas-Díaz, Rikke Kyhnau, Eugenio Ingribelli, Vera Neuzil-Bunesova, Qing Li, Mari Sasaki, Roger P. Lauener, Caroline Roduit, Remo Frei, CK-CARE Study Group, Ulrik Sundekilde, Clarissa Schwab
ABSTRACT Previous studies indicated an intrinsic relationship between infant diet, intestinal microbiota composition and fermentation activity with a strong focus on the role of breastfeeding on microbiota composition. Yet, microbially formed short-chain fatty acids acetate, propionate and butyrate and other fermentation metabolites such as lactate not only act as substrate for bacterial cross-feeding
-
The gut microbiome contributes to somatic morphine withdrawal behavior and implicates a TLR2 mediated mechanism Gut Microbes (IF 12.2) Pub Date : 2023-08-17 Bridget Truitt, Greeshma Venigalla, Praveen Singh, Salma Singh, Junyi Tao, Irina Chupikova, Sabita Roy
ABSTRACT The ongoing opioid epidemic has left millions of people suffering from opioid use disorder due to the over-prescription of highly addictive substances. Chronic opioid exposure leads to dependence, where the absence of the drug results in negative symptoms of withdrawal, often driving patients to continue drug use; however, few therapeutic strategies are currently available to combat the cycle
-
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human Gut Microbes (IF 12.2) Pub Date : 2023-08-17 Edoardo Zaccaria, Tim Klaassen, Annick M.E. Alleleyn, Jos Boekhorst, Christian Chervaux, Tamara Smokvina, Freddy J. Troost, Michiel Kleerebezem
ABSTRACT Fermented foods and beverages are a significant source of dietary bacteria that enter the gastrointestinal (GI) tract. However, little is known about how these microbes survive and adapt to the small intestinal environment. Colony-forming units (CFU) enumeration and viability qPCR of Lacticaseibacillus rhamnosus CNCM I-3690 in the ileal effluent of 10 ileostomy subjects during 12-h post consumption
-
Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism Gut Microbes (IF 12.2) Pub Date : 2023-08-09 Shiwan Hu, Qiyou Ding, Wei Zhang, Mengjiao Kang, Jing Ma, Linhua Zhao
ABSTRACT A growing amount of evidence has supported that gut microbiota plays a vital role in the reproductive endocrine system throughout a woman’s whole life, and gut microbial β-glucuronidase (gmGUS) is a key factor in regulating host estrogen metabolism. Moreover, estrogen levels also influence the composition as well as the diversity of gut microbiota. In normal condition, the gmGUS-estrogen crosstalk
-
The importance of the gut microbiome in the pathogenesis and transmission of SARS-CoV-2 Gut Microbes (IF 12.2) Pub Date : 2023-08-09 Carlo Brogna, Valentina Viduto, Mark Fabrowski, Simone Cristoni, Giuliano Marino, Luigi Montano, Marina Piscopo
ABSTRACT Zhou et al. study nicely traces a significant topic in COVID-19 infection: the persistence of the virus within the intestinal tract. Many pathological mechanisms have been noted in the current literature about the mode of infection and propagation of SARS-CoV-2 in the human body. Nevertheless, there are still many concerns about this: only some things seem well understood. We present a different
-
Exosomal-miR-129-2-3p derived from Fusobacterium nucleatum-infected intestinal epithelial cells promotes experimental colitis through regulating TIMELESS-mediated cellular senescence pathway Gut Microbes (IF 12.2) Pub Date : 2023-08-07 Shuchun Wei, Xiaohan Wu, Meilin Chen, Zixuan Xiang, Xiangyun Li, Jixiang Zhang, Weiguo Dong
ABSTRACT Fusobacterium nucleatum (Fn) infection is known to exacerbate ulcerative colitis (UC). However, the link between Fn-infected intestinal epithelial cell (IEC)-derived exosomes (Fn-Exo) and UC progression has not been investigated. Differentially expressed miRNAs in Fn-Exo and non-infected IECs-derived exosomes (Con-Exo) were identified by miRNA sequencing. Then, the biological role and mechanism
-
Robust cross-cohort gut microbiome associations with COVID-19 severity Gut Microbes (IF 12.2) Pub Date : 2023-08-07 Junhui Li, Tarini Shankar Ghosh, Rachel McCann, Patrick Mallon, Colin Hill, Lorraine Draper, David Schult, Liam J. Fanning, Robert Shannon, Corinna Sadlier, Mary Horgan, Liam O’Mahony, Paul W. O’Toole
ABSTRACT Although many recent studies have examined associations between the gut microbiome and COVID-19 disease severity in individual patient cohorts, questions remain on the robustness across international cohorts of the biomarkers they reported. Here, we performed a meta-analysis of eight shotgun metagenomic studies of COVID-19 patients (comprising 1,023 stool samples) and 23 > 16S rRNA gene amplicon
-
Intracellular glycogen accumulation by human gut commensals as a niche adaptation trait Gut Microbes (IF 12.2) Pub Date : 2023-08-01 Maria Esteban-Torres, Lorena Ruiz, Valerio Rossini, Ken Nally, Douwe van Sinderen
ABSTRACT The human gut microbiota is a key contributor to host metabolism and physiology, thereby impacting in various ways on host health. This complex microbial community has developed many metabolic strategies to colonize, persist and survive in the gastrointestinal environment. In this regard, intracellular glycogen accumulation has been associated with important physiological functions in several
-
Genetic and gut microbiome determinants of SCFA circulating and fecal levels, postprandial responses and links to chronic and acute inflammation Gut Microbes (IF 12.2) Pub Date : 2023-08-01 Ana Nogal, Francesco Asnicar, Amrita Vijay, Afroditi Kouraki, Alessia Visconti, Panayiotis Louca, Kari Wong, Andrei-Florin Baleanu, Francesca Giordano, Jonathan Wolf, George Hadjigeorgiou, Richard Davies, Gregory A. Michelotti, Paul W. Franks, Sarah E. Berry, Mario Falchi, Adeel Ikram, Benjamin J. Ollivere, Amy Zheng, Jessica Nightingale, Massimo Mangino, Nicola Segata, William J. Bulsiewicz, Tim D
ABSTRACT Short-chain fatty acids (SCFA) are involved in immune system and inflammatory responses. We comprehensively assessed the host genetic and gut microbial contribution to a panel of eight serum and stool SCFAs in two cohorts (TwinsUK, n = 2507; ZOE PREDICT-1, n = 328), examined their postprandial changes and explored their links with chronic and acute inflammatory responses in healthy individuals
-
The phospholipase effector Tle1Vc promotes Vibrio cholerae virulence by killing competitors and impacting gene expression Gut Microbes (IF 12.2) Pub Date : 2023-08-01 Ming Liu, Heng Wang, Ying Liu, Miao Tian, Zhao Wang, Run-Dong Shu, Meng-Yu Zhao, Wei-Di Chen, Hao Wang, Hui Wang, Yang Fu
ABSTRACT Vibrio cholerae utilizes the Type VI secretion system (T6SS) to gain an advantage in interbacterial competition by delivering anti-prokaryotic effectors in a contact-dependent manner. However, the impact of T6SS and its secreted effectors on physiological behavior remains poorly understood. In this study, we present Tle1Vc, a phospholipase effector in atypical pathogenic V. cholerae E1 that
-
Citizen science helps to raise awareness about gut microbiome health in people at risk of developing non-communicable diseases Gut Microbes (IF 12.2) Pub Date : 2023-08-02 Silvia Garcia, Sheyla Ordoñez, Victor Manuel López-Molina, Blanca Lacruz-Pleguezuelos, Enrique Carrillo de Santa Pau, Laura Judith Marcos-Zambrano
ABSTRACT Citizens lack knowledge about the impact of gut microbiota on health and how lifestyle and dietary choices can influence it, leading to Non-Communicable Diseases (NCDs) and affecting overall well-being. Participatory action research (PAR) is a promising approach to enhance communication and encourage individuals to adopt healthier behaviors and improve their health. In this study, we explored
-
Protection against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid Gut Microbes (IF 12.2) Pub Date : 2023-07-28 Jijun Tan, Ruizhi Hu, Jiatai Gong, Chengkun Fang, Yanli Li, Ming Liu, Ziyu He, De-Xing Hou, Hongfu Zhang, Jianhua He, Shusong Wu
ABSTRACT Gut microbiota–diet interaction has been identified as a key factor of metabolic associated fatty liver disease (MAFLD). Recent studies suggested that dietary polyphenols may protect against MAFLD by regulating gut microbiota; however, the underlying mechanisms remain elusive. We first investigated the effects of cyanidin 3-glucoside and its phenolic metabolites on high-fat diet induced MAFLD
-
Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization Gut Microbes (IF 12.2) Pub Date : 2023-07-27 Ziyu Huang, Yue Li, Heekuk Park, Martin Ho, Kanchan Bhardwaj, Naoki Sugimura, Hye Won Lee, Huicui Meng, Matthias P. Ebert, Kang Chao, Elke Burgermeister, Aadra P. Bhatt, Sudarshan A. Shetty, Kai Li, Weiping Wen, Tao Zuo
ABSTRACT The world is witnessing a global increase in the urban population, particularly in developing Asian and African countries. Concomitantly, the global burden of non-communicable diseases (NCDs) is rising, markedly associated with the changing landscape of lifestyle and environment during urbanization. Accumulating studies have revealed the role of the gut microbiome in regulating the immune
-
Colorectal cancer and gut microbiota studies in China Gut Microbes (IF 12.2) Pub Date : 2023-07-23 Zikai Wang, Wanyue Dan, Nana Zhang, Jingyuan Fang, Yunsheng Yang
ABSTRACT Colorectal cancer (CRC) is the third most common malignant tumor worldwide. The incidence and mortality rates of CRC have been increasing in China, possibly due to economic development, lifestyle, and dietary changes. Evidence suggests that gut microbiota plays an essential role in the tumorigenesis of CRC. Gut dysbiosis, specific pathogenic microbes, metabolites, virulence factors, and microbial
-
Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota Gut Microbes (IF 12.2) Pub Date : 2023-07-18 Zarwa Saqib, Giada De Palma, Jun Lu, Michael Surette, Premysl Bercik, Stephen Michael Collins
ABSTRACT Compositional changes in the microbiota (dysbiosis) may be a basis for Irritable Bowel Syndrome (IBS), but biomarkers are currently unavailable to direct microbiota-directed therapy. We therefore examined whether changes in fecal β-defensin could be a marker of dysbiosis in a murine model. Experimental dysbiosis was induced using four interventions relevant to IBS: a mix of antimicrobials
-
Shifting pattern of gut microbiota in pregnant women two decades apart – an observational study Gut Microbes (IF 12.2) Pub Date : 2023-07-19 Samuli Rautava, Marta Selma-Royo, Teo Oksanen, Maria Carmen Collado, Erika Isolauri
ABSTRACT Background: Past decades have witnessed a decrease in environmental biodiversity. We hypothesized a similar decrease in indigenous gut microbiota diversity, which may have contributed to the obesity epidemic. Objective: To investigate the changes in the composition and function of the gut microbiota in pregnant women over a period of 20 years. Study design: Altogether 124 pregnant women (41
-
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection Gut Microbes (IF 12.2) Pub Date : 2023-07-19 Hongliang Tian, Jiaqu Cui, Chen Ye, Jiangman Zhao, Bo Yang, Yue Xu, Shushen Ji, Le Wang, Xiaoqiong Lv, Chunlian Ma, Shailan Zhou, Ning Li, Xinjun Wang, Huanlong Qin, Qiyi Chen
ABSTRACT Approximately 10% of individuals diagnosed with Clostridium difficile infection (CDI) show the resistance to fecal microbiota transplantation (FMT), with the underlying mechanisms remaining elusive. Deciphering the intricate microbiome profile within this particular subset of FMT-refractory patients via clinical FMT investigations assumes paramount importance, as it holds the key to designing
-
Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice Gut Microbes (IF 12.2) Pub Date : 2023-07-20 Joshua M. Borin, Roland Liu, Yanhan Wang, Tsung-Chin Wu, Jessica Chopyk, Lina Huang, Peiting Kuo, Chandrabali Ghose, Justin R. Meyer, Xin M. Tu, Bernd Schnabl, David T. Pride
ABSTRACT The gastrointestinal microbiome plays a significant role in modulating numerous host processes, including metabolism. Prior studies show that when mice receive fecal transplants from obese donors on high-fat diets (HFD) (even when recipient mice are fed normal diets after transplantation), they develop obese phenotypes, demonstrating the prominent role that gut microbiota play in determining
-
Transplantation of gut microbiota from old mice into young healthy mice reduces lean mass but not bone mass Gut Microbes (IF 12.2) Pub Date : 2023-07-20 Lina Lawenius, Carrie Cowardin, Louise Grahnemo, Julia M. Scheffler, Karin Horkeby, Cecilia Engdahl, Jianyao Wu, Liesbeth Vandenput, Antti Koskela, Juha Tukkanen, Eivind Coward, Kristian Hveem, Arnulf Langhammer, Sanna Abrahamsson, Jeffrey I. Gordon, Klara Sjögren, Claes Ohlsson
ABSTRACT Aging is associated with low bone and lean mass as well as alterations in the gut microbiota (GM). In this study, we determined whether the reduced bone mass and relative lean mass observed in old mice could be transferred to healthy young mice by GM transplantation (GMT). GM from old (21-month-old) and young adult (5-month-old) donors was used to colonize germ-free (GF) mice in three separate
-
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection Gut Microbes (IF 12.2) Pub Date : 2023-07-13 Siwen Bao, Hao Wang, Wang Li, Haisheng Wu, Chunying Lu, Liang Yong, Qing Zhang, Xiang Lu, Min Zhao, Juan Lu, Jia Liu, Chukwudozie Kingsley Ikechukwu, Juan Xu, Ping Ni, Ying Xiong, Wen Zhang, Chenglin Zhou
ABSTRACT Diarrhea is a leading cause of morbidity and mortality in children worldwide and represents a major dysbiosis event. Rotavirus has been recognized as a global leading pathogen of diarrhea. This study is aimed at investigating differences in the gut virome between diarrheal children and healthy controls. In 2018, 76 diarrheal fecal samples and 27 healthy fecal samples in Shanghai and 40 diarrheal
-
Longitudinal flux balance analyses of a patient with episodic colonic inflammation reveals microbiome metabolic dynamics Gut Microbes (IF 12.2) Pub Date : 2023-07-12 Arianna Basile, Almut Heinken, Johannes Hertel, Larry Smarr, Weizhong Li, Laura Treu, Giorgio Valle, Stefano Campanaro, Ines Thiele
ABSTRACT We report the first use of constraint-based microbial community modeling on a single individual with episodic inflammation of the gastrointestinal tract, who has a well documented set of colonic inflammatory biomarkers, as well as metagenomically-sequenced fecal time series covering seven dates over 16 months. Between the first two time steps the individual was treated with both steroids and
-
Phenylpropionic acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity Gut Microbes (IF 12.2) Pub Date : 2023-07-11 Sungjoon Cho, Xiaotong Yang, Kyoung-Jae Won, Vanessa A. Leone, Eugene B. Chang, Grace Guzman, Yeonju Ko, Ok-Nam Bae, Hyunwoo Lee, Hyunyoung Jeong
ABSTRACT The gut microbiota affects hepatic drug metabolism. However, gut microbial factors modulating hepatic drug metabolism are largely unknown. In this study, using a mouse model of acetaminophen (APAP)-induced hepatotoxicity, we identified a gut bacterial metabolite that controls the hepatic expression of CYP2E1 that catalyzes the conversion of APAP to a reactive, toxic metabolite. By comparing
-
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications Gut Microbes (IF 12.2) Pub Date : 2023-07-11 Nityanand Jain, Tungki Pratama Umar, Anne-Fleur Fahner, Valdis Gibietis
ABSTRACT Clostridioides difficile infections (CDI) are a leading cause of healthcare-associated infections with a high relapse rate. Current treatment guidelines recommend fidaxomicin as the primary therapy for initial CDI episodes and suggest alternative approaches for recurrent episodes, including fecal microbiota transplantation (FMT). This paper explores the recent approval of Vowst, a novel oral
-
Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis Gut Microbes (IF 12.2) Pub Date : 2023-07-11 Bing Han, Xiaodan Lv, Gengfeng Liu, Shiquan Li, Junhua Fan, Lan Chen, Zhixi Huang, Guangfu Lin, Xiaofang Xu, Ziqian Huang, Lingling Zhan, Xiaoping Lv
ABSTRACT The gut microbiota and bile acid metabolism are key determinants of the response of inflammatory bowel disease to biologic therapy. However, the molecular mechanisms underlying the interactions between the response to anti-α4β7-integrin therapy and the gut microbiota and bile acid metabolism remain unknown. In this research, we investigated the role of gut microbiota-related bile acid metabolism
-
A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines Gut Microbes (IF 12.2) Pub Date : 2023-07-11 Ming Hong, Tin Lan, Qiuxia Li, Binfei Li, Yong Yuan, Feng Xu, Weijia Wang
ABSTRACT The efficacy of COVID-19 vaccines varies between individuals and populations, and the reasons for this are still not fully understood. Recent clinical studies and animal models have indicated that the gut microbiota may influence the immunogenicity of the vaccine and, thus, its effectiveness. This suggests that there is a bidirectional relationship between the gut microbiota and the COVID-19
-
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet Gut Microbes (IF 12.2) Pub Date : 2023-07-10 Jonathan M. Keane, Vanessa Las Heras, Jorge Pinheiro, Jamie A. FitzGerald, María A. Núñez-Sánchez, Cara M. Hueston, Liam O’Mahony, Paul D. Cotter, Colin Hill, Silvia Melgar, Cormac G. M. Gahan
ABSTRACT A high-fat (HF) diet reduces resistance to the foodborne pathogen Listeria monocytogenes. We demonstrate that short-term gavage with A. muciniphila increases resistance to oral and systemic L. monocytogenes infection in mice fed a HF diet. A. muciniphila reduced inflammation in the gut and liver of mice fed a high-fat diet prior to infection and reduced inflammatory cell infiltration in the
-
Maturation of the gut metabolome during the first year of life in humans Gut Microbes (IF 12.2) Pub Date : 2023-07-10 Runze Ouyang, Juan Ding, Yan Huang, Fujian Zheng, Sijia Zheng, Yaorui Ye, Qi Li, Xiaolin Wang, Xiao Ma, Yuxin Zou, Rong Chen, Zhihong Zhuo, Zhen Li, Qi Xin, Lina Zhou, Xin Lu, Zhigang Ren, Xinyu Liu, Petia Kovatcheva-Datchary, Guowang Xu
ABSTRACT The gut microbiota is involved in the production of numerous metabolites that maintain host wellbeing. The assembly of the gut microbiome is highly dynamic, and influenced by many postnatal factors, moreover, little is known about the development of the gut metabolome. We showed that geography has an important influence on the microbiome dynamics in the first year of life based on two independent
-
Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia-related propanoate metabolism Gut Microbes (IF 12.2) Pub Date : 2023-07-10 Caihan Duan, Junhao Wu, Zhe Wang, Chen Tan, Lingzhi Hou, Wei Qian, Chaoqun Han, Xiaohua Hou
ABSTRACT Intestinal stem cells (ISCs) are critical for the development and rapid turnover of intestinal epithelium. The regulatory effects of gut microbiota and their metabolites on ISCs stemness remain elusive. Fucose has been demonstrated to mediate host–microbe interactions in the intestine. However, the association between fucose, gut bacteria, and ISCs stemness remains unclear. To investigate
-
Short-term mucosal disruption enables colibactin-producing E. coli to cause long-term perturbation of colonic homeostasis Gut Microbes (IF 12.2) Pub Date : 2023-07-10 Christine Harnack, Hilmar Berger, Lichao Liu, Hans-Joachim Mollenkopf, Till Strowig, Michael Sigal
ABSTRACT Colibactin, a bacterial genotoxin produced by E. coli strains harboring the pks genomic island, induces cytopathic effects, such as DNA breaks, cell cycle arrest, and apoptosis. Patients with inflammatory bowel diseases, such as ulcerative colitis, display changes in their microbiota with the expansion of E. coli. Whether and how colibactin affects the integrity of the colonic mucosa and whether
-
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes Gut Microbes (IF 12.2) Pub Date : 2023-07-07 Rahul Gomes, Ashleigh Denison Kroschel, Stephanie Day, Rick Jansen
ABSTRACT Virulent genes present in Escherichia coli (E. coli) can cause significant human diseases. These enteropathogenic E. coli (EPEC) and enterotoxigenic E. coli (ETEC) isolates with virulent genes show different expression levels when grown under diverse laboratory conditions. In this research, we have performed differential gene expression analysis using publicly available RNA-seq data on three
-
Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in ApcMin/+ mice Gut Microbes (IF 12.2) Pub Date : 2023-07-07 Héloïse Chat, Guillaume Dalmasso, Catherine Godfraind, Virginie Bonnin, Racha Beyrouthy, Mathilde Bonnet, Nicolas Barnich, Amel Mettouchi, Emmanuel Lemichez, Richard Bonnet, Julien Delmas
ABSTRACT Colorectal cancer (CRC) patients are frequently colonized by colibactin-producing Escherichia coli (CoPEC) (>40%), which enhances tumorigenesis in mouse models of CRC. We observed that 50% of CoPEC also contains the cnf1 gene, which encodes cytotoxic necrotizing factor-1 (CNF1), an enhancer of the eukaryotic cell cycle. The impact of its co-occurrence with colibactin (Clb) has not yet been
-
Dynamic effects of probiotic formula ecologic®825 on human small intestinal ileostoma microbiota: a network theory approach Gut Microbes (IF 12.2) Pub Date : 2023-07-07 Jack Jansma, Nicola U. Thome, Markus Schwalbe, Anastasia Chrysovalantou Chatziioannou, Somayah S. Elsayed, Gilles P. van Wezel, Pieter van den Abbeele, Saskia van Hemert, Sahar El Aidy
ABSTRACT The gut microbiota plays a pivotal role in health and disease. The use of probiotics as microbiota-targeted therapies is a promising strategy to improve host health. However, the molecular mechanisms involved in such therapies are often not well understood, particularly when targeting the small intestinal microbiota. In this study, we investigated the effects of a probiotic formula (Ecologic®825)
-
Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic Gut Microbes (IF 12.2) Pub Date : 2023-07-05 Wenyi Xu, Jiaqi Yu, Yanan Yang, Zhuanyu Li, Yinghui Zhang, Fang Zhang, Qingshi Wang, Yong Xie, Bowen Zhao, Chongming Wu
ABSTRACT Compelling evidence has tightly linked gut microbiota with host metabolism homeostasis and inspired novel therapeutic potentials against metabolic diseases (e.g., hyperlipidemia). However, the regulatory profile of individual bacterial species and strain on lipid homeostasis remains largely unknown. Herein, we performed a large-scale screening of 2250 human gut bacterial strains (186 species)
-
Better together–Salmonella biofilm-associated antibiotic resistance Gut Microbes (IF 12.2) Pub Date : 2023-07-04 Adrianna Aleksandrowicz, Ewa Carolak, Agata Dutkiewicz, Aleksandra Błachut, Wiktoria Waszczuk, Krzysztof Grzymajlo
ABSTRACT Salmonella poses a serious threat to public health and socioeconomic development worldwide because of its foodborne pathogenicity and antimicrobial resistance. This biofilm-planktonic lifestyle enables Salmonella to interfere with the host and become resistant to drugs, conferring inherent tolerance to antibiotics. The complex biofilm structure makes bacteria tolerant to harsh conditions due
-
Maternal microbiome disturbance induces deficits in the offspring’s behaviors: a systematic review and meta-analysis Gut Microbes (IF 12.2) Pub Date : 2023-07-03 Lucas Hassib, Cilene Lino de Oliveira, Guilherme Araujo Rouvier, Alexandre Kanashiro, Francisco Silveira Guimarães, Frederico Rogério Ferreira
ABSTRACT Recent evidence has suggested that changes in maternal gut microbiota in early life may generate neurobiological consequences associated with psychiatric-related abnormalities. However, the number of studies on humans investigating this problem is limited, and preclinical findings sometimes conflict. Therefore, we run a meta-analysis to examine whether maternal microbiota disturbance (MMD)
-
Limosilactobacillus reuteri DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial Gut Microbes (IF 12.2) Pub Date : 2023-07-04 Richard A. Forsgård, Julia Rode, Karin Lobenius-Palmér, Annalena Kamm, Snehal Patil, Mirriam G. J. Tacken, Marleen A. H. Lentjes, Jakob Axelsson, Gianfranco Grompone, Scott Montgomery, Robert J. Brummer
ABSTRACT Studies have shown that probiotics can decrease the symptoms of respiratory tract infections as well as increase antibody responses following certain vaccinations. We examined the effect of probiotic supplementation on anti-SARS-CoV-2 specific antibody responses upon SARS-CoV-2 infection as well as after COVID-19 vaccination. In this randomized, triple-blinded, placebo-controlled intervention